生物医药产业集群风险的因素诊断与层次分析——基于上海三类园区的案例研究  

Factor Identification and Hierarchical Analysis of Risks in Biopharmaceutical Industry Clusters:Case Study in Shanghai

作　　者：孙洁[1] Sun Jie(Shanghai Academy of Social Sciences,Institute of Applied Economics,Shanghai 200020,China)

机构地区：[1]上海社会科学院应用经济研究所,上海200020

出　　处：《中国科技论坛》2021年第12期62-69,108,共9页Forum on Science and Technology in China

基　　金：上海市科技创新行动计划软科学研究重点项目“上海生物医药产业集群风险的因素诊断与层次分析:基于张江园区、枫林联盟和东方美谷的比较研究”(20692106800)。

摘　　要：后疫情时期,生物医药产业获得逆势上扬的机遇,但也同样面临风险。本文选择上海3个代表性园区张江、枫林和东方美谷进行跨案例研究,探讨生物医药产业集群风险的各类因素,根据风险因素之间的直接关系建立邻接关系矩阵,按照层级顺序把风险因素分层,建立集群风险系统的ISM解析结构模型。研究发现:生物医药产业集群风险系统的递阶结构中,各风险因素对集群风险系统的诱发程度与作用范围有所差异,各底层要素均对顶层的技术创新基础要素产生直接或者间接影响。从内源角度,区位和体制是造成生物医药产业集群风险的重要因素;从外源角度,竞争环境、政策环境和产业生态环境是重要外在因素。In the post epidemic period,the biopharmaceutical industry has the opportunity to rise,but it also faces the risk.This paper selects Zhangjiang,Fenglin and the Oriental Beauty Valley,three representative parks in Shanghai,to conduct a case study and explore the risk factors of biopharmaceutical industry clusters.According to the direct relationship between risk factors,the adjacency relationship matrix is established.According to the hierarchical order,the risk factors are layered,and the ISM analytic structure model of cluster risk system is established.The results show the followings.The hierarchical structure of the risk system of biopharmaceutical industry cluster has five levels of characteristics.The bottom elements will directly or indirectly affect the top-level basic elements of technological innovation.Location and system are the important factors.The competitive environment,policy environment and industrial ecological environment are the important external factors.

关 键 词：生物医药产业 集群风险 层次分析 案例研究 上海 

分 类 号：F062.9[经济管理—政治经济学]